Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Tinnitus Therapy

K-Number: K260614 · 2026-06-10

ApplicantSivantos GmbH
Decision Date2026-06-10
Product CodeKLW
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

Tinnitus Therapy is the device name listed in this FDA 510(k) record. The listed applicant is Sivantos GmbH. It received FDA 510(k) clearance on 2026-06-10 under 510(k) number K260614. The device is classified under product code KLW. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Tinnitus Therapy?

Tinnitus Therapy is a medical device that received FDA 510(k) clearance on 2026-06-10. The listed applicant is Sivantos GmbH. The 510(k) number is K260614.

When did Tinnitus Therapy receive FDA 510(k) clearance?

Tinnitus Therapy received FDA 510(k) clearance on 2026-06-10, under 510(k) number K260614.

Who is the listed applicant for Tinnitus Therapy?

The FDA 510(k) record lists Sivantos GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Tinnitus Therapy?

The FDA product code for Tinnitus Therapy is KLW.

Related Devices (Code: KLW)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.